AAC -- Table of Contents (February 1 1996, 40 [2])

Receive this page by e-mail each issue: [Sign up for eTOCs]

Contents: February 1996, Volume 40, Issue 2

       Minireviews

       Articles

       Letters

Other Issues

FREE CONTENT FROM ASM

AUTHOR-SPONSORED OPEN ACCESS

Table of Contents

To see an article, click its [Full Text], [Abstract] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Minireviews:

Antifungal agents: chemotherapeutic targets and immunologic strategies
NH Georgopapadakou and TJ Walsh
Antimicrob. Agents Chemother. February 1996 40: 279-291;
[PDF] [Reprints and Permissions]

Articles:

Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease
AK Patick, H Mo, M Markowitz, K Appelt, B Wu, L Musick, V Kalish, S Kaldor, S Reich, D Ho, and S Webber
Antimicrob. Agents Chemother. February 1996 40: 292-297;
[Abstract] [PDF] [Reprints and Permissions]

Activity of KRM-1648 in combination with isoniazid against Mycobacterium tuberculosis in a murine model
SP Klemens and MH Cynamon
Antimicrob. Agents Chemother. February 1996 40: 298-301;
[Abstract] [PDF] [Reprints and Permissions]

Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids
BW Petschow, RP Batema, and LL Ford
Antimicrob. Agents Chemother. February 1996 40: 302-306;
[Abstract] [PDF] [Reprints and Permissions]

Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance
JL Burns, CD Wadsworth, JJ Barry, and CP Goodall
Antimicrob. Agents Chemother. February 1996 40: 307-313;
[Abstract] [PDF] [Reprints and Permissions]

Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia
PH Edelstein, MA Edelstein, J Ren, R Polzer, and RP Gladue
Antimicrob. Agents Chemother. February 1996 40: 314-319;
[Abstract] [PDF] [Reprints and Permissions]

Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN- alpha
JM Pawlotsky, AG Hovanessian, F Roudot-Thoraval, N Robert, M Bouvier, G Babany, J Duval, and D Dhumeaux
Antimicrob. Agents Chemother. February 1996 40: 320-324;
[Abstract] [PDF] [Reprints and Permissions]

Assessment of two penicillins plus beta-lactamase inhibitors versus cefotaxime in treatment of murine Klebsiella pneumoniae infections [published erratum appears in Antimicrob Agents Chemother 1996 Oct;40(10):2441]
JL Fournier, F Ramisse, AC Jacolot, M Szatanik, OJ Petitjean, JM Alonso, and MR Scavizzi
Antimicrob. Agents Chemother. February 1996 40: 325-330;
[Abstract] [PDF] [Reprints and Permissions]

The anti-human immunodeficiency virus agent 3'-fluorothymidine induces DNA damage and apoptosis in human lymphoblastoid cells
R Sundseth, SS Joyner, JT Moore, RE Dornsife, and IK Dev
Antimicrob. Agents Chemother. February 1996 40: 331-335;
[Abstract] [PDF] [Reprints and Permissions]

Evolution of drug resistance in Salmonella panama isolates in Chile
AM Cordano and R Virgilio
Antimicrob. Agents Chemother. February 1996 40: 336-341;
[Abstract] [PDF] [Reprints and Permissions]

In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum- cephalosporins
L Martinez-Martinez, S Hernandez-Alles, S Alberti, JM Tomas, VJ Benedi, and GA Jacoby
Antimicrob. Agents Chemother. February 1996 40: 342-348;
[Abstract] [PDF] [Reprints and Permissions]

Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems
K Senda, Y Arakawa, K Nakashima, H Ito, S Ichiyama, K Shimokata, N Kato, and M Ohta
Antimicrob. Agents Chemother. February 1996 40: 349-353;
[Abstract] [PDF] [Reprints and Permissions]

Modification of penicillin-binding protein 5 associated with high-level ampicillin resistance in Enterococcus faecium
M Ligozzi, F Pittaluga, and R Fontana
Antimicrob. Agents Chemother. February 1996 40: 354-357;
[Abstract] [PDF] [Reprints and Permissions]

In vitro and in vivo inhibition of erythrocytic development of malarial parasites by docetaxel
V Sinou, P Grellier, and J Schrevel
Antimicrob. Agents Chemother. February 1996 40: 358-361;
[Abstract] [PDF] [Reprints and Permissions]

MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci
MA Visalli, MR Jacobs, and PC Appelbaum
Antimicrob. Agents Chemother. February 1996 40: 362-366;
[Abstract] [PDF] [Reprints and Permissions]

Inhibition of poliovirus replication by prostaglandins A and J in human cells
C Conti, P Mastromarino, P Tomao, A De Marco, F Pica, and MG Santoro
Antimicrob. Agents Chemother. February 1996 40: 367-372;
[Abstract] [PDF] [Reprints and Permissions]

Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C. difficile toxins
CP Kelly, C Pothoulakis, F Vavva, I Castagliuolo, EF Bostwick, JC O'Keane, S Keates, and JT LaMont
Antimicrob. Agents Chemother. February 1996 40: 373-379;
[Abstract] [PDF] [Reprints and Permissions]

Inhibition of hepatitis B virus by a novel L-nucleoside, 2'-fluoro-5- methyl-beta-L-arabinofuranosyl uracil
S Balakrishna Pai, SH Liu, YL Zhu, CK Chu, and YC Cheng
Antimicrob. Agents Chemother. February 1996 40: 380-386;
[Abstract] [PDF] [Reprints and Permissions]

Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers
M Oethinger, S Conrad, K Kaifel, A Cometta, J Bille, G Klotz, MP Glauser, R Marre, and WV Kern
Antimicrob. Agents Chemother. February 1996 40: 387-392;
[Abstract] [PDF] [Reprints and Permissions]

Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice
B Ji, EG Perani, C Petinom, and JH Grosset
Antimicrob. Agents Chemother. February 1996 40: 393-399;
[Abstract] [PDF] [Reprints and Permissions]

Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice
MJ Hickey, TM Arain, RM Shawar, DJ Humble, MH Langhorne, JN Morgenroth, and CK Stover
Antimicrob. Agents Chemother. February 1996 40: 400-407;
[Abstract] [PDF] [Reprints and Permissions]

Single-dose rufloxacin versus 3-day norfloxacin treatment of uncomplicated cystitis: clinical evaluation and pharmacodynamic considerations
G Del Rio, F Dalet, L Aguilar, J Caffaratti, and R Dal-Re
Antimicrob. Agents Chemother. February 1996 40: 408-412;
[Abstract] [PDF] [Reprints and Permissions]

The guanine nucleoside analog penciclovir is active against chronic duck hepatitis B virus infection in vivo
E Lin, C Luscombe, YY Wang, T Shaw, and S Locarnini
Antimicrob. Agents Chemother. February 1996 40: 413-418;
[Abstract] [PDF] [Reprints and Permissions]

Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance
FS Clark, T Parkinson, CA Hitchcock, and NA Gow
Antimicrob. Agents Chemother. February 1996 40: 419-425;
[Abstract] [PDF] [Reprints and Permissions]

In vitro bactericidal and in vivo therapeutic activities of a new rifamycin derivative, KRM-1648, against Mycobacterium tuberculosis
T Yamamoto, R Amitani, K Suzuki, E Tanaka, T Murayama, and F Kuze
Antimicrob. Agents Chemother. February 1996 40: 426-428;
[Abstract] [PDF] [Reprints and Permissions]

Activity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige mice
T Yamamoto, R Amitani, K Suzuki, E Tanaka, T Murayama, and F Kuze
Antimicrob. Agents Chemother. February 1996 40: 429-432;
[Abstract] [PDF] [Reprints and Permissions]

Anticytomegaloviral activity of methotrexate associated with preferential accumulation of drug by cytomegalovirus-infected cells
M Wachsman, FM Hamzeh, H Saito, and PS Lietman
Antimicrob. Agents Chemother. February 1996 40: 433-436;
[Abstract] [PDF] [Reprints and Permissions]

How effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice?
B Ji, N Lounis, C Truffot-Pernot, and J Grosset
Antimicrob. Agents Chemother. February 1996 40: 437-442;
[Abstract] [PDF] [Reprints and Permissions]

Characterization of squalene epoxidase activity from the dermatophyte Trichophyton rubrum and its inhibition by terbinafine and other antimycotic agents
B Favre and NS Ryder
Antimicrob. Agents Chemother. February 1996 40: 443-447;
[Abstract] [PDF] [Reprints and Permissions]

2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo
F Zoulim, E Dannaoui, C Borel, O Hantz, TS Lin, SH Liu, C Trepo, and YC Cheng
Antimicrob. Agents Chemother. February 1996 40: 448-453;
[Abstract] [PDF] [Reprints and Permissions]

Chromosomal beta-lactamase genes of Klebsiella oxytoca are divided into two main groups, blaOXY-1 and blaOXY-2
B Fournier, PH Roy, PH Lagrange, and A Philippon
Antimicrob. Agents Chemother. February 1996 40: 454-459;
[Abstract] [PDF] [Reprints and Permissions]

beta-lactamase gene promoters of 71 clinical strains of Klebsiella oxytoca
B Fournier, PH Lagrange, and A Philippon
Antimicrob. Agents Chemother. February 1996 40: 460-463;
[Abstract] [PDF] [Reprints and Permissions]

Some repair-deficient mutants of Dictyostelium discoideum display enhanced susceptibilities to bleomycin
RA Deering, RB Guyer, L Stevens, and TE Watson-Thais
Antimicrob. Agents Chemother. February 1996 40: 464-467;
[Abstract] [PDF] [Reprints and Permissions]

Clarithromycin in treatment of early Lyme disease: a pilot study
RJ Dattwyler, E Grunwaldt, and BJ Luft
Antimicrob. Agents Chemother. February 1996 40: 468-469;
[Abstract] [PDF] [Reprints and Permissions]

Selective cytotoxicity of ricin A chain immunotoxins towards murine cytomegalovirus-infected cells
BB Barnett, DF Smee, SM Malek, and RW Sidwell
Antimicrob. Agents Chemother. February 1996 40: 470-472;
[Abstract] [PDF] [Reprints and Permissions]

Mode of action of GR122222X, a novel inhibitor of bacterial DNA gyrase
M Oram, B Dosanjh, NA Gormley, CV Smith, LM Fisher, A Maxwell, and K Duncan
Antimicrob. Agents Chemother. February 1996 40: 473-476;
[Abstract] [PDF] [Reprints and Permissions]

Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori
J Versalovic, D Shortridge, K Kibler, MV Griffy, J Beyer, RK Flamm, SK Tanaka, DY Graham, and MF Go
Antimicrob. Agents Chemother. February 1996 40: 477-480;
[Abstract] [PDF] [Reprints and Permissions]

Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci
SK Spangler, MR Jacobs, and PC Appelbaum
Antimicrob. Agents Chemother. February 1996 40: 481-484;
[Abstract] [PDF] [Reprints and Permissions]

Investigation of bioequivalence and tolerability of intramuscular ceftriaxone injections by using 1% lidocaine, buffered lidocaine, and sterile water diluents
CJ Hayward, AN Nafziger, SJ Kohlhepp, and JS Bertino, Jr
Antimicrob. Agents Chemother. February 1996 40: 485-487;
[Abstract] [PDF] [Reprints and Permissions]

Enzymatic method for inactivation of aminoglycosides during measurement of postantibiotic effect
JG den Hollander, JW Mouton, IA Bakker-Woudenberg, FP Vleggaar, MP van Goor, and HA Verbrugh
Antimicrob. Agents Chemother. February 1996 40: 488-490;
[Abstract] [PDF] [Reprints and Permissions]

Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli
J Vila, J Ruiz, P Goni, and MT De Anta
Antimicrob. Agents Chemother. February 1996 40: 491-493;
[Abstract] [PDF] [Reprints and Permissions]

Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains
AS Bayer, MD Witt, E Kim, and MA Ghannoum
Antimicrob. Agents Chemother. February 1996 40: 494-496;
[Abstract] [PDF] [Reprints and Permissions]

Influence of external factors in resistance of Corynebacterium urealyticum to antimicrobial agents
M Garcia-Bravo, JM Aguado, JM Morales, and AR Noriega
Antimicrob. Agents Chemother. February 1996 40: 497-499;
[Abstract] [PDF] [Reprints and Permissions]

Unique susceptibility of Helicobacter pylori to simethicone emulsifiers in alimentary therapeutic agents
AV Kane and AG Plaut
Antimicrob. Agents Chemother. February 1996 40: 500-502;
[Abstract] [PDF] [Reprints and Permissions]

Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis
J Carratala, A Fernandez-Sevilla, F Tubau, MA Dominguez, and F Gudiol
Antimicrob. Agents Chemother. February 1996 40: 503-505;
[Abstract] [PDF] [Reprints and Permissions]

The erythromycin resistance gene from the Bacteroides conjugal transposon Tcr Emr 7853 is nearly identical to ermG from Bacillus sphaericus
AJ Cooper, NB Shoemaker, and AA Salyers
Antimicrob. Agents Chemother. February 1996 40: 506-508;
[Abstract] [PDF] [Reprints and Permissions]

Sequences of beta-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other beta- lactamases
A Bauernfeind, I Stemplinger, R Jungwirth, S Ernst, and JM Casellas
Antimicrob. Agents Chemother. February 1996 40: 509-513;
[Abstract] [PDF] [Reprints and Permissions]

In vitro potency of inhibition by antiviral drugs of hematopoietic progenitor colony formation correlates with exposure at hemotoxic levels in human immunodeficiency virus-positive humans
RE Dornsife and DR Averett
Antimicrob. Agents Chemother. February 1996 40: 514-519;
[Abstract] [PDF] [Reprints and Permissions]

(-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (524W91) inhibits hepatitis B virus replication in primary human hepatocytes
LD Condreay, JP Condreay, RW Jansen, MT Paff, and DR Averett
Antimicrob. Agents Chemother. February 1996 40: 520-523;
[Abstract] [PDF] [Reprints and Permissions]

Letters:

Insufficient evidence of synergistic effect of levofloxacin and rifampin against Legionella pneumophila
ML van Ogtrop
Antimicrob. Agents Chemother. February 1996 40: 524-525;
[PDF] [Reprints and Permissions]

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.